Fengru Lin, TurtleTree CEO and co-founder

Fengru Lin, TurtleTree CEO and co-founder © TurtleTree

Fermentation

TurtleTree Secures First-Ever Vegan Certification in Precision Fermentation Dairy

After obtaining self-GRAS status last November for its animal-free lactoferrin, LF+, TurtleTree, a Singaporean biotech company operating in California, USA, announces that the product has officially obtained vegan certification.  TrutleTree’s protein and manufacturing process has been certified by Vegan Action, the leading vegan certification provider in the US. The vegan stamp ensures that consumers can trust the absence of animal products, byproducts, and animal testing in their products. According to the Singaporean biotech, this milestone establishes it as the first precision fermentation dairy company globally to obtain vegan certification. Meanwhile, it also marks the first time that Vegan Action gives the stamp to a novel protein in its 24-year trajectory with more than 15,000 products Vegan Certified. Fengru Lin, CEO and co-founder of TurtleTree, comments: …

more

TurtleTree receives approval to commercialize animal-free lactoferrin in the USA

© TurtleTree

Fermentation

TurtleTree Obtains First-Ever Self-GRAS Status for Precision Fermentation-Derived Lactoferrin

Singaporean biotech TurtleTree claims that it has obtained the world’s first self-GRAS status (generally recognized as safe) by the FDA for a precision fermentation-derived lactoferrin, making it also the first Singaporean company to obtain self-GRAS for a synbio protein. This status confirms that TurtleTree’s animal-free lactoferrin is safe for human consumption, allowing the company to commercialize it in the USA. In May, the company unveiled the protein, branded under L+, claiming it as the world’s first animal-free lactoferrin. TurtleTree announced that it will supply LF+ for infant formulas, plant-based dairy, and sports nutrition products, including protein powders, functional beverages, meal replacement alternatives, and multivitamins, expecting profitability in 2024. The biotech company also announced that multiple clients have shown interest in buying a $500 million value of animal-free lactoferrin …

more